Page last updated: 2024-08-21

pyrazines and fibrinogen

pyrazines has been researched along with fibrinogen in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, SF; Peng, W1
Fujisawa, Y; Fukushi, H; Imai, Y; Kawamura, M; Kita, S; Miyawaki, T; Sugihara, H; Terashita, Z1
Corral, J; de Arriba, F; Ferrer, F; González, M; Hernández-Espinosa, D; Martínez, C; Miñano, A; Mota, RA; Ordoñez, A; Pérez-Ceballos, E; Vicente, V1
Affeld, K; Dohmen, PM; Kertzscher, U; Konertz, W; Linneweber, J1
Björkman, JA; Jones, HB; Schofield, J1

Trials

1 trial(s) available for pyrazines and fibrinogen

ArticleYear
Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin.
    Laboratory investigation; a journal of technical methods and pathology, 2008, Volume: 88, Issue:3

    Topics: Alleles; alpha 1-Antitrypsin; Animals; Antineoplastic Agents; Antithrombins; Boronic Acids; Bortezomib; Carcinoma, Hepatocellular; Case-Control Studies; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Endoplasmic Reticulum; Factor Xa Inhibitors; Fibrinogen; Humans; Immunohistochemistry; Injections, Intravenous; Leukocyte Elastase; Liver; Liver Neoplasms; Male; Mice; Molecular Chaperones; Multiple Myeloma; Proteasome Inhibitors; Proteins; Pyrazines; Serpins; Ubiquitin

2008

Other Studies

4 other study(ies) available for pyrazines and fibrinogen

ArticleYear
[Effect of ligustrazine controlled release capsule on hemorrheology in patients with cor pulmonale].
    Zhonghua nei ke za zhi, 1993, Volume: 32, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Aged; Blood Viscosity; Delayed-Action Preparations; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Pulmonary Heart Disease; Pyrazines; Thromboxane B2

1993
Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
    Journal of medicinal chemistry, 1998, Feb-12, Volume: 41, Issue:4

    Topics: Animals; Drug Design; Fibrinogen; Guanidines; Guinea Pigs; Humans; In Vitro Techniques; Kinetics; Molecular Structure; Oligopeptides; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines; Structure-Activity Relationship

1998
Local glycoprotein IIb/IIIa receptor inhibitor delivery from the pump surface attenuates platelet adhesion in continuous flow ventricular assist devices.
    Artificial organs, 2008, Volume: 32, Issue:10

    Topics: Adsorption; Blood Platelets; Delayed-Action Preparations; Fibrinogen; Guanidines; Heart-Assist Devices; Hemorheology; Humans; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines

2008
Coronary and systemic arterial physiology and immunohistochemical markers related to early coronary arterial lesions in beagle dogs given the potassium channel opener, ZD6169, or the endothelin receptor antagonist, ZD1611.
    Toxicologic pathology, 2013, Volume: 41, Issue:5

    Topics: Amides; Animals; Arteritis; Benzophenones; Biomarkers; Blood Pressure; Coronary Vessels; Dogs; Electrocardiography; Female; Fibrinogen; Heart; Heart Rate; Immunohistochemistry; Myocardium; Pyrazines; Sulfonamides; von Willebrand Factor

2013